⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for nkt2152

Every month we try and update this database with for nkt2152 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)NCT05935748
ccRCC
Clear Cell Rena...
Kidney Cancer
Kidney Neoplasm...
Renal Cancer
Renal Neoplasms
Recurrent Renal...
Metastatic Rena...
Refractory Rena...
Advanced Renal ...
Carcinoma
Neoplasms
Carcinoma, Rena...
Neoplasms, Glan...
Neoplasm by His...
Adenocarcinoma
Urologic Neopla...
Urogenital Neop...
Neoplasms by Si...
Kidney Diseases
Urologic Diseas...
NKT2152
palbociclib
sasanlimab
18 Years - NiKang Therapeutics, Inc.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: